课题基金 / 基金详情

BIOLOGICAL FATE AND BIOCOMPATIBILITY OF SILICA-BASED NANOCONSTRUCTS

BIOLOGICAL FATE AND BIOCOMPATIBILITY OF SILICA-BASED NANOCONSTRUCTS
二氧化硅基纳米结构的生物命运和生物相容性
批准号:
10579946
负责人:
Hamid Ghandehari
金额:
$50.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
未结题
起止时间:
2007-09-28 至 2026-11-30

项目摘要

项目成果

Hamid Ghandehari的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY A major challenge with systemic administration of silica nanoparticles (SNPs) is clearance by and accumulation in organs of mononuclear phagocytic system (MPS), and subsequent immune response. Poor loading capacity of SNPs, their stability and vacuolization in macrophages, and potentially lower metabolism and clearance rates in patient populations may necessitate administration of high and frequent doses of SNPs which could lead to MPS saturation and overload. Detailed investigation of immunotoxicity of SNPs in the MPS is needed to establish their safety profile to choose drug carriers with well-defined immunological properties. The influence of SNPs on the fate and function of phagocytes after uptake and saturation, and on host immune response need further elucidation. The correlation between the physicochemical properties of SNPs and the mechanisms of sex-dependent toxicity is unclear. Also, the immune response alteration upon i.v. administration of SNPs and the mechanisms behind this response are largely unknown. To address these knowledge gaps in this grant application the following Specific Aims are proposed: 1) To investigate the influence of saturation of macrophages with SNPs on their phagocytic activity, survival, proliferation, and immune signaling as a function of nanoparticle physicochemical properties. The underlying hypothesis to be tested in this aim is that saturation of macrophages by SNPs will influence their normal function, molecular signaling, and fate based on nanoparticle characteristics. 2) To investigate bone marrow toxicity and function of tissue-resident macrophages after i.v. administration of SNPs, and assess the number and activation status of circulating phagocytes after in vitro exposure to SNPs. The underlying hypothesis to be tested in this aim is that size, geometry, and porosity of SNPs influence the normal function of bone marrow, tissue-resident macrophages, and peripheral blood phagocytes, a phenomenon which may be reversible and depend on dose and frequency of administration. 3) To investigate the immune side effects and anti-PEG response of systemically administered SNPs as a function of animal sex and particle physicochemical properties. The underlying hypotheses are: i) Anti-PEG IgM and IgG will be generated in a time-dependent manner upon exposure to PEGylated SNPs; ii) variation in immune response in female vs male Th1 and Th2 bias animal models will contribute to SNP toxicity and immune- mediated side effects. This proposal is significant because understanding key physicochemical properties of SNPs with well- defined immunological properties will help establish safer platforms for intravenous drug delivery. It is innovative because for the first time it approaches different SNP interactions with various components of the immune system as a result of animal-sex and different immune-biased in a systematic fashion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Localized delivery of glycosaminoclycan ethers for the treatment of radiation-induced proctitis
  • 批准号:
    10296670
  • 项目类别:
  • 资助金额:
    $33.52万
  • 财政年份:
    2018
  • 负责人:
    Hamid Ghandehari
  • 依托单位:
Localized delivery of glycosaminoclycan ethers for the treatment of radiation-induced proctitis
  • 批准号:
    10530585
  • 项目类别:
  • 资助金额:
    $30.41万
  • 财政年份:
    2018
  • 负责人:
    Hamid Ghandehari
  • 依托单位:
Localized delivery of glycosaminoclycan ethers for the treatment of radiation-induced proctitis
  • 批准号:
    10058818
  • 项目类别:
  • 资助金额:
    $34.2万
  • 财政年份:
    2018
  • 负责人:
    Hamid Ghandehari
  • 依托单位:
In-situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma
  • 批准号:
    8314876
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2012
  • 负责人:
    Hamid Ghandehari
  • 依托单位:
海外基金